Hypotheses on the neuroimmune cross-talk between COVID-19 and neuropsychiatric disorders
- PMID: 34303538
- PMCID: PMC8282431
- DOI: 10.1016/j.psyneuen.2021.105359
Hypotheses on the neuroimmune cross-talk between COVID-19 and neuropsychiatric disorders
Keywords: COVID-19; Cytokines; Depression; Mental health; Neuropsychiatric disorders.
Comment on
-
Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19.Psychoneuroendocrinology. 2021 Sep;131:105295. doi: 10.1016/j.psyneuen.2021.105295. Epub 2021 Jun 3. Psychoneuroendocrinology. 2021. PMID: 34119855 Free PMC article.
References
-
- Del Valle D.M., Kim-Schulze S., Huang H.H., Beckmann N.D., Nirenberg S., Wang B., Lavin Y., Swartz T.H., Madduri D., Stock A., Marron T.U., Xie H., Patel M., Tuballes K., Van Oekelen O., Rahman A., Kovatch P., Aberg J.A., Schadt E., Jagannath S., Mazumdar M., Charney A.W., Firpo-Betancourt A., Mendu D.R., Jhang J., Reich D., Sigel K., Cordon-Cardo C., Feldmann M., Parekh S., Merad M., Gnjatic S. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 2020;26:1636–1643. doi: 10.1038/s41591-020-1051-9. - DOI - PMC - PubMed
-
- Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., Laue M., Schneider J., Brünink S., Greuel S., Lehmann M., Hassan O., Aschman T., Schumann E., Chua R.L., Conrad C., Eils R., Stenzel W., Windgassen M., Rößler L., Heppner F.L. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2021;24:168–175. doi: 10.1038/s41593-020-00758-5. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
